ホーム
探索
nav.journalClub
トレンド
その他
synapse
⌘+K
言語
日本語
How is AI developing in pharmacovigilance? | Synapse
March 3, 2026
Open Access
How is AI developing in pharmacovigilance?
AB
Andrew Bate
PT
Philip Tregunno
Key Points
AI plays a crucial role in pharmacovigilance, improving detection of adverse events through data mining and predictive analytics.
The analysis shows a significant increase in adverse event reporting efficiency when utilizing artificial intelligence technologies.
Approach includes leveraging various data sources to enhance pharmacovigilance processes, emphasizing real-time safety monitoring.
This highlights the potential for AI to significantly improve drug safety protocols, needing further implementation studies.
Read Full Paper
externally
Mark Helpful
Like
Save
Bookmark
Relay
Share
View Full Paper
Cite This Study
Copy
Bate et al. (Thu,) studied this question.
synapsesocial.com/papers/69a75f4dc6e9836116a2a946
https://doi.org/https://doi.org/10.1177/20420986251412773
Mark Helpful
Like
Save
Bookmark
Relay
Share
View Full Paper